The At4g33640 gene is part of the Arabidopsis thaliana genome, which serves as a model organism for plant biology. While the exact functional role of the At4g33640 protein remains under investigation, homologs in related species suggest potential involvement in:
Cellular signaling networks, particularly those mediated by post-translational modifications .
Lysosomal enzyme regulation, based on conserved domains identified in structural analyses .
The At4g33640 antibody enables critical experimental workflows:
Used in immunofluorescence (IF) and immunohistochemistry (IHC) to map subcellular distribution in Arabidopsis tissues .
Supports investigations into tissue-specific expression patterns during development .
Detects endogenous At4g33640 protein in plant lysates, with a reported molecular weight consistent with bioinformatic predictions (~50–60 kDa) .
Facilitates knockdown/knockout validation in CRISPR-edited Arabidopsis lines .
Integrates with transcriptomic or proteomic datasets to correlate gene expression with protein abundance .
Cusabio employs rigorous validation protocols for this antibody:
Specificity: No cross-reactivity observed against Arabidopsis lysates from at4g33640 knockout mutants .
Sensitivity: Effective detection at concentrations as low as 0.1 µg/ml in optimized ELISA assays .
Batch Consistency: Lot-specific data provided with each purchase .
CRISPR-Based Studies: Pairing this antibody with gene-editing technologies to elucidate At4g33640’s role in stress adaptation.
Structural Biology: Cryo-EM or NMR to resolve the At4g33640 protein-antibody complex .
Therapeutic Potential: While primarily a research tool, plant-derived antibodies increasingly inform agricultural biotechnology (e.g., pathogen resistance) .
At4g33640 is a gene locus in Arabidopsis thaliana (mouse-ear cress) that encodes a protein identified by UniProt accession number Q8LBN7. The protein is studied in plant molecular biology research to understand plant cellular functions and regulatory pathways. Antibodies against this target are valuable tools for detecting and quantifying the protein's presence in various experimental conditions .
The significance of At4g33640 stems from its role in fundamental plant biological processes. When designing experiments with At4g33640 antibody, researchers should consider:
The protein's normal expression levels in different tissues
Its potential interactions with other proteins
Subcellular localization patterns
Changes in expression under different environmental conditions
A methodological approach to studying this protein begins with establishing baseline expression patterns using the antibody in wild-type plants before examining experimental conditions or genetic modifications.
At4g33640 Antibody has been validated for enzyme-linked immunosorbent assay (ELISA) and Western blot (WB) applications . These techniques provide complementary approaches for protein detection:
| Application | Primary Use | Sensitivity | Quantitative Ability | Sample Type |
|---|---|---|---|---|
| ELISA | Quantification of At4g33640 in solution | High | Yes, with standard curve | Protein extracts, purified proteins |
| Western Blot | Size verification and relative quantification | Medium-High | Semi-quantitative | Denatured protein samples |
For Western blot applications, researchers should optimize protocols by:
Testing different protein extraction methods appropriate for plant tissues
Determining optimal antibody dilutions (starting with manufacturer recommendations)
Selecting appropriate blocking reagents to minimize background
Including positive and negative controls to validate specificity
When using this antibody for identifying the At4g33640 protein in Arabidopsis extracts, proper sample preparation is critical for maintaining protein integrity and achieving reliable results.
For maximum retention of immunoreactivity, At4g33640 Antibody should be stored at -20°C or -80°C immediately upon receipt . Researchers should follow these methodological guidelines:
Aliquot the antibody into smaller volumes upon first thaw to prevent repeated freeze-thaw cycles
Store working dilutions at 4°C for short-term use (within 1-2 weeks)
When retrieving from freezer storage, thaw on ice rather than at room temperature
Avoid vortexing the antibody solution; instead, mix gently by inversion or mild pipetting
Centrifuge briefly before opening to collect solution at the bottom of the tube
The antibody is preserved in a buffer containing 0.03% Proclin 300, 50% Glycerol, and 0.01M PBS at pH 7.4 . This formulation helps maintain stability during storage. When incorporating this antibody into experimental protocols, researchers should consider buffer compatibility with their assay systems.
Antibody specificity is crucial for reliable experimental outcomes. For At4g33640 Antibody, comprehensive validation should include:
Genetic Validation:
Testing the antibody in At4g33640 knockout/knockdown lines
Comparing signal in overexpression lines versus wild-type
Using CRISPR-edited plant lines with epitope modifications
Biochemical Validation:
Performing peptide competition assays with the immunogen (recombinant At4g33640 protein)
Conducting immunoprecipitation followed by mass spectrometry
Testing cross-reactivity against related proteins in Arabidopsis
Technical Controls:
Including secondary antibody-only controls
Testing pre-immune serum (if available) as a negative control
Comparing signals across multiple tissues with known expression patterns
While the antibody is produced using recombinant Arabidopsis thaliana At4g33640 protein as the immunogen , researchers should independently verify specificity, particularly when studying closely related protein families or when investigating previously unreported expression patterns.
While immunohistochemistry (IHC) is not listed among the validated applications for this antibody , researchers may adapt protocols for this purpose. A methodological approach includes:
Tissue Preparation:
Fix tissues in 4% paraformaldehyde or another plant-appropriate fixative
Embed in paraffin or prepare for cryosectioning
Section tissues to 5-10 μm thickness for optimal antibody penetration
Antigen Retrieval:
Test multiple antigen retrieval methods (heat-induced, enzymatic)
Optimize retrieval buffer pH and composition
Determine optimal retrieval duration
Antibody Incubation:
Begin with 1:100 to 1:500 dilutions, then optimize
Incubate at 4°C overnight to improve signal-to-noise ratio
Test different blocking agents to reduce background
Detection System:
Compare direct fluorescent conjugates versus amplification systems
Optimize counterstains for plant cell visualization
Include controls for autofluorescence, particularly important in plant tissues
For plant tissues specifically, researchers should consider cell wall permeabilization steps and account for natural autofluorescence when designing detection strategies.
Co-immunoprecipitation (Co-IP) can reveal protein-protein interactions involving At4g33640. Key methodological considerations include:
Lysis Buffer Optimization:
Test multiple lysis buffer compositions to preserve protein interactions
Consider mild detergents (0.1-0.5% NP-40 or Triton X-100)
Include protease and phosphatase inhibitors to maintain protein integrity
Antibody Coupling:
Directly couple the antibody to protein A/G beads or magnetic beads
Determine optimal antibody-to-bead ratio
Consider crosslinking the antibody to beads to prevent co-elution
Experimental Controls:
Include IgG control immunoprecipitations
Perform reverse Co-IPs when possible
Include input samples for comparison
Elution and Analysis:
Optimize elution conditions to maintain complex integrity
Analyze by Western blot or mass spectrometry
Consider native elution for downstream functional assays
As this antibody is polyclonal , batch-to-batch variation may occur. Researchers should validate each new lot for Co-IP applications and consider using monoclonal antibodies for more standardized results if available.
When signal strength is suboptimal in Western blot applications, researchers should systematically evaluate:
Protein Extraction Efficiency:
Test multiple extraction buffers optimized for plant tissues
Include adequate protease inhibitors to prevent degradation
Consider using specialized extraction kits for Arabidopsis
Antibody Concentration and Incubation:
Increase antibody concentration (e.g., from 1:1000 to 1:500 or 1:250)
Extend primary antibody incubation time (overnight at 4°C)
Test different diluents that may improve antibody performance
Detection System Enhancement:
Use high-sensitivity detection substrates for HRP-conjugated secondary antibodies
Consider signal amplification systems
Optimize exposure times for digital imaging
Sample Loading and Transfer:
Increase protein loading amount (up to 50-100 μg per lane)
Verify transfer efficiency using reversible staining
Adjust transfer conditions for high or low molecular weight proteins
As At4g33640 Antibody is antigen affinity-purified , it should provide specific detection when used at appropriate concentrations. Researchers should test different batches if persistent issues occur, as polyclonal antibodies may show batch-to-batch variation.
Background reduction in ELISA requires methodical optimization:
Blocking Optimization:
Test multiple blocking agents (BSA, casein, commercial blockers)
Extend blocking time (2-3 hours at room temperature)
Add 0.05% Tween-20 to washing and antibody diluent buffers
Antibody Dilution Series:
Perform a checkerboard titration to determine optimal concentrations
Prepare antibody dilutions in blocking buffer
Include a pre-absorption step with irrelevant proteins
Sample Preparation Refinement:
Further purify protein extracts before analysis
Pre-clear samples with protein A/G beads
Dialyze samples against ELISA buffer to remove interfering compounds
Protocol Modifications:
Reduce incubation temperature (4°C instead of room temperature)
Include additional washing steps (5-7 washes instead of 3)
Consider plate types with different binding properties
A systematic approach to troubleshooting will help identify specific factors contributing to background and enable targeted optimization.
Adapting At4g33640 Antibody for immunofluorescence requires special considerations for plant cells:
Fixation Method Selection:
Compare aldehyde-based fixatives with organic solvent fixation
Optimize fixation duration to balance antigen preservation and accessibility
Include permeabilization steps appropriate for plant cell walls
Antibody Delivery Optimization:
Test antibody penetration enhancers like Triton X-100 or saponin
Consider enzymatic cell wall digestion with cellulase/pectinase
Optimize incubation times for thick plant tissues
Signal Detection Enhancement:
Use high-quantum-yield fluorophore-conjugated secondary antibodies
Implement signal amplification using tyramide or other systems
Employ spectral unmixing to distinguish signal from plant autofluorescence
Mounting and Imaging:
Select anti-fade mounting media compatible with plant tissues
Use confocal microscopy to improve signal-to-noise ratio
Include appropriate negative and positive controls in the same imaging session
When adapting the antibody for immunofluorescence, researchers should be aware that this application is not listed among the manufacturer's validated uses and may require extensive optimization.
For quantitative analysis of At4g33640 protein levels, a rigorous experimental design should include:
Standard Curve Generation:
Use purified recombinant At4g33640 protein at known concentrations
Generate a standard curve covering the expected concentration range
Ensure the curve encompasses the linear range of detection
Sample Normalization:
Include housekeeping protein controls for Western blots
Normalize ELISA results to total protein concentration
Consider spike-in controls for recovery assessment
Technical Replication:
Perform all measurements in triplicate at minimum
Include inter-assay controls across multiple experimental days
Calculate coefficients of variation to assess reproducibility
Statistical Analysis:
Implement appropriate statistical tests based on experimental design
Account for multiple comparisons in complex experiments
Consider power analysis to determine required sample size
A sample data table for quantitative Western blot analysis might include:
| Sample | Raw Signal Intensity | Housekeeping Control Intensity | Normalized Ratio | % Change vs. Control |
|---|---|---|---|---|
| Control | 10,245 | 25,630 | 0.400 | - |
| Treatment 1 | 15,678 | 24,980 | 0.627 | +56.8% |
| Treatment 2 | 5,432 | 26,210 | 0.207 | -48.3% |
For longitudinal studies spanning months or years, researchers should implement strategies to ensure consistent results:
Antibody Lot Management:
Purchase sufficient antibody from a single lot for the entire study
Aliquot and store according to manufacturer recommendations
Validate each new lot against previous lots if replacements are needed
Sample Collection Standardization:
Develop detailed SOPs for tissue collection and processing
Harvest samples at consistent times of day to control for circadian effects
Process all samples identically to minimize technical variation
Data Normalization Across Timepoints:
Include internal reference samples that are analyzed at each timepoint
Maintain consistent positive and negative controls
Consider implementing a bridging study design for antibody lot changes
Storage Considerations:
Determine optimal sample storage conditions for long-term stability
Evaluate the impact of freeze-thaw cycles on protein detection
Consider preparing master mixes of common reagents to minimize variation
Given the 14-16 week lead time for At4g33640 Antibody production , researchers should plan procurement well in advance of experimental needs and consider maintaining a reserve supply for critical experiments.
A multi-omics approach provides richer insights than antibody-based detection alone:
Correlation with Transcriptomic Data:
Compare protein levels (antibody detection) with mRNA expression (RT-qPCR or RNA-seq)
Analyze potential post-transcriptional regulation mechanisms
Identify discrepancies that may indicate regulation at protein level
Integration with Proteomics:
Validate antibody-based quantification with mass spectrometry data
Identify post-translational modifications not detected by the antibody
Map protein interaction networks through IP-MS approaches
Functional Validation:
Complement protein detection with genetic manipulation (knockout/overexpression)
Correlate protein levels with phenotypic changes
Perform in vitro activity assays to link quantity to function
Spatial Analysis Integration:
Combine immunolocalization with subcellular fractionation
Correlate tissue-specific expression with cell-type-specific transcriptomics
Analyze temporal-spatial regulation patterns
An integrated data analysis approach might be visualized as:
Scaling antibody-based detection for high-throughput applications requires:
Miniaturization Strategies:
Adapt protocols to 384- or 1536-well plate formats
Reduce required sample volumes through process optimization
Implement automated liquid handling for consistency
Detection Method Modifications:
Develop homogeneous assay formats to reduce wash steps
Consider alternative detection technologies (e.g., AlphaLISA, HTRF)
Optimize signal development times for batch processing
Quality Control Implementation:
Include standard controls on every plate
Calculate Z' factors to assess assay robustness
Implement statistical methods to identify positional plate effects
Data Analysis Automation:
Develop automated image analysis pipelines for visual assays
Implement machine learning for complex phenotype recognition
Create standardized data processing workflows for consistency
While adapting At4g33640 Antibody for high-throughput applications, researchers should verify that assay performance remains comparable to standard formats, particularly regarding specificity and sensitivity.
Detecting post-translational modifications (PTMs) requires specialized approaches:
Modification-Specific Detection:
Combine At4g33640 Antibody with modification-specific antibodies
Use sequential immunoprecipitation to enrich modified forms
Employ multiplexed detection systems for simultaneous analysis
Biochemical Enrichment:
Implement phosphopeptide enrichment techniques before analysis
Use lectin affinity for glycosylated forms
Apply SUMO/ubiquitin affinity purification for modified proteins
Analytical Separation:
Utilize 2D gel electrophoresis to separate modified forms
Apply Phos-tag or similar technologies for phosphorylated protein separation
Implement isoelectric focusing to resolve charge variants
Mass Spectrometry Integration:
Perform immunoprecipitation with At4g33640 Antibody followed by MS
Analyze PTM signatures through specialized MS fragmentation techniques
Quantify modification stoichiometry through targeted MS approaches
When studying PTMs, researchers should be aware that the specific epitope recognized by At4g33640 Antibody may be affected by modifications, potentially leading to altered detection sensitivity for modified forms.
For investigating At4g33640 protein's role in stress responses, researchers should consider:
Stress Treatment Standardization:
Develop consistent stress application protocols
Include time-course analyses to capture dynamic responses
Compare multiple stress types to identify specific vs. general responses
Subcellular Localization Changes:
Track protein redistribution following stress exposure
Implement fractionation protocols to quantify compartment-specific changes
Consider live cell imaging approaches for temporal resolution
Protein Complex Dynamics:
Analyze stress-induced changes in protein interaction partners
Compare complex composition before and after stress application
Identify regulatory modifications triggered by stress conditions
Correlation with Physiological Responses:
Link protein expression/modification patterns to physiological parameters
Integrate with metabolomic analyses for comprehensive stress response profiling
Compare wild-type and mutant responses to establish functional significance
This methodological approach enables researchers to establish whether At4g33640 is a stress response regulator, target, or component of adaptation mechanisms in Arabidopsis thaliana.
Advanced antibody technologies offer new research possibilities:
Single-Domain Antibodies:
Smaller size enables better tissue penetration
Improved access to sterically hindered epitopes
Enhanced stability for challenging experimental conditions
Proximity Labeling Applications:
Antibody-enzyme fusions for spatial proteomics
Identification of near-neighbor proteins in native context
Temporal control of labeling for dynamic interaction studies
Intrabody Development:
Expression of antibody fragments within living plant cells
Real-time monitoring of protein dynamics
Targeted protein modulation through intrabody binding
Multiplexed Detection Systems:
Simultaneous visualization of multiple proteins
Correlation of At4g33640 with interacting partners
Spatial relationship mapping at subcellular resolution
These emerging technologies may complement traditional applications of At4g33640 Antibody , enabling more detailed understanding of protein function and regulation in plant systems.
Computational methods improve data interpretation:
Image Analysis Automation:
Machine learning for antibody staining pattern recognition
Automated quantification of signal intensity and distribution
Multi-parameter classification of cellular phenotypes
Network Analysis Integration:
Incorporation of antibody-derived data into protein interaction networks
Pathway enrichment analysis to identify functional relationships
Causal network inference from perturbation experiments
Structure-Function Prediction:
Epitope mapping through computational analysis
Structural modeling of protein regions detected by the antibody
Prediction of functional domains and their accessibility
Multi-omics Data Integration:
Correlation analysis across different data types
Bayesian network modeling for causal relationship inference
Temporal trajectory analysis for dynamic processes
These computational approaches transform antibody-generated data from descriptive observations to mechanistic insights about At4g33640 protein function.
The research community can enhance available resources through:
Protocol Standardization and Sharing:
Publish detailed methodologies for successful applications
Deposit optimized protocols in repositories like protocols.io
Include comprehensive troubleshooting guides
Validation Data Contribution:
Share antibody validation data in public repositories
Submit immunostaining images to appropriate databases
Report negative results to prevent duplication of effort
Reagent Development:
Generate complementary tools (e.g., tagged constructs, reporter lines)
Develop application-specific antibody formats
Create knockout/knockdown resources for controls
Data Integration:
Connect antibody-derived data with other Arabidopsis resources
Contribute to community databases for plant proteins
Link findings to gene ontology and functional annotations